ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
SANUWAVE Health Inc (QB)

SANUWAVE Health Inc (QB) (SNWV)

28.00
0.00
(0.00%)
Closed February 27 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
28.00
Bid
27.68
Ask
29.95
Volume
-
0.00 Day's Range 0.00
4.275 52 Week Range 29.1925
Market Cap
Previous Close
28.00
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
9,209
Shares Outstanding
1,181,272,961
Dividend Yield
-
PE Ratio
-1,284.40
Earnings Per Share (EPS)
-0.02
Revenue
20.4M
Net Profit
-25.81M

About SANUWAVE Health Inc (QB)

SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE's portfolio of products and product cand... SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE's portfolio of products and product candidates activate biologic signaling and angiogenic responses, including revascularization and microcirculatory improvement, helping restore the body's normal healing processes and regeneration. SANUWAVE is applying its Pulsed Acoustic Cellular Expression (PACE) technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Carson City, Nevada, USA
Founded
-
SANUWAVE Health Inc (QB) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker SNWV. The last closing price for SANUWAVE Health (QB) was $28. Over the last year, SANUWAVE Health (QB) shares have traded in a share price range of $ 4.275 to $ 29.1925.

SANUWAVE Health (QB) currently has 1,181,272,961 shares outstanding. The market capitalization of SANUWAVE Health (QB) is $33.08 billion. SANUWAVE Health (QB) has a price to earnings ratio (PE ratio) of -1284.40.

SNWV Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.461.6702977487327.5428.5526.04594227.62195416CS
40.51.8181818181827.528.5523.55595926.84801835CS
128.4243.003064351419.5829.192518.502920924.67061531CS
2621.82353.0744336576.1829.19255.212527495410.413625CS
5218.625198.6666666679.37529.19254.2753206398.43776438CS
156-35.75-56.078431372563.7569.3750.52534786410.44608051CS
260-78.875-73.8011695906106.875112.50.037533244034.14202693CS

SNWV - Frequently Asked Questions (FAQ)

What is the current SANUWAVE Health (QB) share price?
The current share price of SANUWAVE Health (QB) is $ 28.00
How many SANUWAVE Health (QB) shares are in issue?
SANUWAVE Health (QB) has 1,181,272,961 shares in issue
What is the market cap of SANUWAVE Health (QB)?
The market capitalisation of SANUWAVE Health (QB) is USD 33.08B
What is the 1 year trading range for SANUWAVE Health (QB) share price?
SANUWAVE Health (QB) has traded in the range of $ 4.275 to $ 29.1925 during the past year
What is the PE ratio of SANUWAVE Health (QB)?
The price to earnings ratio of SANUWAVE Health (QB) is -1.28k
What is the cash to sales ratio of SANUWAVE Health (QB)?
The cash to sales ratio of SANUWAVE Health (QB) is 1.62k
What is the reporting currency for SANUWAVE Health (QB)?
SANUWAVE Health (QB) reports financial results in USD
What is the latest annual turnover for SANUWAVE Health (QB)?
The latest annual turnover of SANUWAVE Health (QB) is USD 20.4M
What is the latest annual profit for SANUWAVE Health (QB)?
The latest annual profit of SANUWAVE Health (QB) is USD -25.81M
What is the registered address of SANUWAVE Health (QB)?
The registered address for SANUWAVE Health (QB) is 112 NORTH CURRY STREET, CARSON CITY, NEVADA, 89703
What is the SANUWAVE Health (QB) website address?
The website address for SANUWAVE Health (QB) is sanuwave.com
Which industry sector does SANUWAVE Health (QB) operate in?
SANUWAVE Health (QB) operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABVFAberdeen International Inc (PK)
$ 0.02282
(0.00%)
0
AABKFAareal Bank AG (CE)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0244
(0.00%)
0
AAALYAareal Bank AG (PK)
$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.02282
(0.00%)
0
AABKFAareal Bank AG (CE)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0244
(0.00%)
0
AAALYAareal Bank AG (PK)
$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
HLGVFHillgrove Resources Ltd (PK)
$ 0.056
(0.00%)
1.87M
IDVVInternational Endeavors Corporation (PK)
$ 0.0004
(0.00%)
1.8M
VLVLYVolvo AB (PK)
$ 32.10
(0.00%)
1.7M
JAPAYJapan Tobacco (PK)
$ 12.45
(0.00%)
1.08M
RRLTFReach Resources Ltd (PK)
$ 0.00
(0.00%)
1M

Discussion

View Full Feed
maddyandboomer maddyandboomer 2 minutes ago
Table 3A shows more than half billion issued to Phillipe in last FY...guessing we will see more
AXXA
pos_stock_hoarder pos_stock_hoarder 3 minutes ago
Cheers!
gladeshawk gladeshawk 3 minutes ago
AIRI>>>>Suggest keeping on your watch lists. With new orders backlog now over $250 Million. Ad to run on CNBC. Just a FYI. HAWK
AIRI
BEIJING BILL BEIJING BILL 3 minutes ago
The chart is churning nicely this week ... Setting up for March.

Buy the dips and sell the rips.

It's coming
ADIA
XMaster2023 XMaster2023 3 minutes ago
For equivalency between Flaskworks and the manual manufacturing method, would NWBO not only need to show a robust immune response within a given period? This is an extremely short duration.
NWBO
maddyandboomer maddyandboomer 3 minutes ago
Phillipe current conversion rate is .00026
AXXA
Golden Cross Golden Cross 4 minutes ago
$NIXX Looking for a strong day as we squeeze the shorts. Zero shares to borrow now!
https://investorshub.advfn.com/uimage/uploads/2025/2/27/hketrNIXX-CTB.png
NIXX
maddyandboomer maddyandboomer 4 minutes ago
1. You don't sell Cds into market

A. You sign a convertible note with a discounted price (i.e.duanne phillipe had a 35 discount) usually lowest pps over previous 20 days b/c you gave company cash.

B. After a year, one can convert for free trading shares assuming company
AXXA
PinkPennies PinkPennies 4 minutes ago
QNRX radar nice news https://ih.advfn.com/stock-market/NASDAQ/quoin-pharmaceuticals-QNRX/stock-news/95526874/quoin-pharmaceuticals-announces-highly-positive
QNRX
wadegarret wadegarret 4 minutes ago
COHR/LITE/ANET- All went down 32% for no reason, and

after blowout reports and guidance. This is why Warren Buffet wants no part of tech stocks. They can crash out of nowhere.
PSIX
TommyJ7651 TommyJ7651 4 minutes ago
I noticed Steve Lines had exercised 335 042 rights (resulting in 335 042 common shares) as recently as 25 February. Always nice to see him commit to more shares since he is in charge of the entire EA process. The key point here is that even though it might sound like a small amount of shares it migh
FFMGF
gladeshawk gladeshawk 5 minutes ago
AIRI>>>Undervalued, imho. With new orders backlog now over $250 Million. Suggest keeping on your watch lists. Just a FYI. HAWK
AIRI
threebabiesbusy threebabiesbusy 5 minutes ago
Posted 15 mins ago….On February 27, 2025, NLS Pharmaceutics announced new preclinical data for AEX-2, a non-sulfonamide dual orexin receptor agonist, highlighting its potential for treating narcolepsy and related neurological disorders. The findings suggest AEX-2 offers a safer and more targeted alt
NLSP
threebabiesbusy threebabiesbusy 5 minutes ago
On February 27, 2025, NLS Pharmaceutics announced new preclinical data for AEX-2, a non-sulfonamide dual orexin receptor agonist, highlighting its potential for treating narcolepsy and related neurological disorders. The findings suggest AEX-2 offers a safer and more targeted alternative to existing
NLSP
dewophile dewophile 5 minutes ago
EDP-323

DDI study just listed yesterday

https://clinicaltrials.gov/study/NCT06847464?term=rsv%20enanta&aggFilters=status:rec&rank=3
ENTA
work-n-hard work-n-hard 5 minutes ago
ULY: .90 picking up steam
ULY
MartinLutherKing MartinLutherKing 5 minutes ago
Premarket $2.75.. 3Million market cap Where do you want it to go… Its a sabotage, Cant you see management are all fraud artists
https://www.transcodetherapeutics.com/leadership.html
RNAZ
BullNBear52 BullNBear52 5 minutes ago
~~COMPX 2/27/2025~~~~~~~

Previous Close

19075.26 +48.88

19252 BullNBear52
19194 SSKILLZ1
COMP
JMCK6193 JMCK6193 5 minutes ago
You're a 🤡 
FOXO
PinkPennies PinkPennies 5 minutes ago
QNRX radar news https://ih.advfn.com/stock-market/NASDAQ/quoin-pharmaceuticals-QNRX/stock-news/95526874/quoin-pharmaceuticals-announces-highly-positive
QNRX
Doubledown75 Doubledown75 5 minutes ago
Gonna be a fun day;)
SPY
PinkPennies PinkPennies 6 minutes ago
QNRX radar news https://ih.advfn.com/stock-market/NASDAQ/quoin-pharmaceuticals-QNRX/stock-news/95526874/quoin-pharmaceuticals-announces-highly-positive
QNRX
gladeshawk gladeshawk 6 minutes ago
AIRI>>>With total backlog going over $250 Million pps has company undervalued, imho. Suggest keeping on your watch lists. Just a FYI. HAWK
AIRI
MightyX MightyX 6 minutes ago
And yall are already on a first-name basis
TPTW
Ask$lapper Ask$lapper 6 minutes ago
GM LD!!